Treatment of diffuse large b-cell lymphosarcoma with involvement of bone marrow in an old female patient

Full Text

Лечение диффузной В-крупноклеточной лимфосаркомы с вовлечением костного мозга у пожилой больной. -


  1. Greiner Т. С., Medeiros L. J., Jaffe Е. S. Non-Hodgkin's lymphoma. Cancer 1995; 75: 370-380.
  2. Groves F. D., Linet M. S., Travis L. B. et al. Cancer surveillance series Non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1987 throught 1995. J. Natl. Cancer Inst. 2000; 92: 1240-1251.
  3. Dixon D. O., Neilan В., Jones S. E. et al. Effect of age on therapeutic outcome in advanced diffuse hystiocytic lymphoma: the Southwest Oncology Group experience. J. Clin. Oncol. 1986; 4: 295-305.
  4. Магомедова А. У., Кременецкая A. M., Воробьев И. А. и др. Прогностическое значение очагового поражения костного мозга при диффузной В-крупноклеточной лимфосаркоме. Тер. арх. 2004; 7: 60-63.
  5. Воробьев А. И. (ред.) Руководство по гематологии. М.: Изд-во "Ньюдиамед"; 2003: т. 2: 57-62.
  6. Skorokhod О., Kulikova Е. K., Galkina N. М. et al. Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded erythrocytes. Haematologica 2007; 92 (4): 570-571.

Copyright (c) 2008 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail:


© 2018-2021 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies